Спонсоры
Trump tariff pressure: AstraZeneca to move production to US, announces $50 billion manufacturing push
Сообщение
AstraZeneca is set to invest $50 billion in the U.S., featuring a large manufacturing plant in Virginia, marking its biggest manufacturing investment. This move aligns with the company's expectation that 50% of its revenue will come from the U.S. by 2030. The decision comes amid rising tariff pressures from the Trump administration, aiming to bolster domestic drug supply chains.
Поиск
Категории
- National
- International
- Business
- Technology
- Health
- Образование
- Sports
- Entertainment
- Travel
- Environment
- Science
- Law
- Agriculture
- Real Estate
- Opinion
- Religion
- Weather
- Automotive
- Social Issues
- Culture
- Sci-Fi & Future
Больше
Russia oil trouble hits: Shipowners and oil traders avoiding Russia-backed Nayara Energy in India; impact after EU sanctions
Global shipping firms and petroleum traders are reportedly avoiding Nayara Energy, an Indian...
Gagan Thapa rules out future electoral alliances for Nepali Congress
CHITWAN: Nepali Congress General Secretary Gagan Kumar Thapa has stated that the party has...
© 2025 Dununu.com : Circle of Life - Santan Social Network
Russian
